DEERFIELD, Ill.--(BUSINESS WIRE)-- Baxter International Inc. (NYSE:BAX), a global leader in acute care, today announced the global launch of PrisMax 2, the latest version of the company’s ...
Baxter International Inc. BAX recently announced the global launch of the latest version of its next-generation platform, PrisMax 2. The PrisMax 2 system aims to help streamline the delivery of ...
Innovative features inspired by clinician feedback make delivering therapy simpler and more efficient Incorporates the latest technology to increase accuracy and performance in delivering therapy for ...
SAN DIEGO--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, announced it has submitted the PrisMax system for 510(k) clearance to the U.S. Food and ...
The PrisMax platform, which was designed based on input from more than 650 providers around the world and received FDA clearance for use in the U.S. in July, supports the treatment of AKI with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results